Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands-Reference-Cited by-同舟云学术

Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands

Published:2008-05 Issue:9 Volume:18 Page:2830-2835
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Worm Karin,Zhou Q. Jean,Saeui Christopher T.,Green Rosalyn C.,Cassel Joel A.,Stabley Gabriel J.,DeHaven Robert N.,Conway-James Nathalie,LaBuda Christopher J.,Koblish Michael,Little Patrick J.,Dolle Roland E.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference23 articles.

1. International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

2. Cannabinoid receptors and pain

3. Pain and cannabinoids: science and evidence

4. Cannabinoid-based drugs as anti-inflammatory therapeutics

5. Cannabinoids and neuroinflammation

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabinoid receptor type 2 ligands: an analysis of granted patents since 2010;Pharmaceutical Patent Analyst;2021-05

2. Synthetic cannabinoid receptor agonists: Analytical profiles and development of QMPSB, QMMSB, QMPCB, 2F‐QMPSB, QMiPSB, and SGT‐233;Drug Testing and Analysis;2020-09-22

3. Natural Products as a Source for Novel Analgesic Compounds;Pain Relief - From Analgesics to Alternative Therapies;2017-05-24

4. Chemistry of Cannabinoid Receptor Agonists;Handbook of Cannabis and Related Pathologies;2017

5. Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists;Chemical Reviews;2016-01-07